Basking Biosciences
PrivateLast Round
Seed Round
Apr 2, 2026
Total Funding Raised
$60.4M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Basking Biosciences is a clinical-stage biopharmaceutical company developing a novel, reversible thrombolytic therapy designed to treat acute ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Basking Biosciences Comparables
Compare Basking Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pharmazz, Inc. | 79% | |
| Aronora, Inc. | 79% | |
| Silver Creek Pharmaceuticals | 75% | |
Basking Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Apr 2, 2026 | ||||
| Series A | Jan 30, 2024 | ||||
| Seed | Dec 7, 2020 |
Key People
Founding team and executive leadership
Basking Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ohio State University | Series A |
| ARCH Venture Partners | Series A |
| Viva BioInnovator | Seed |
| ARCH Venture Partners | Series A |
| Rev1 Ventures | Series A, Seed |
| RTW Investments | Series A |
| Platanus Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2026
Monthly visitors increased 180% MoM, reaching 1.2K.
- Jun 1, 2026
Grew 27% QoQ, from 15 to 19 employees.
Basking Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Basking Biosciences's valuation, stock price, and market status.